As of Feb 27
| -0.27 / -5.06%|
The 4 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 11.50, with a high estimate of 14.00 and a low estimate of 7.00. The median estimate represents a +126.82% increase from the last price of 5.07.
The current consensus among 4 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.